Kent Laboratories, Inc.

Click Here To EMAIL INQUIRY
Contact: Mary P. Jorgensen - International & National Sales Manager
Web: http://www.kentlabs.com
E-Mail:
Address: 777 Jorgensen Pl., Bellingham, Washington 98226, USA
Phone: +1-(360)-398-8641 | Fax: +1-(603)-954-6333 | Map/Directions >>

Profile: Kent Laboratories, Inc. specializes in the production of polyclonal antibodies, radial immunodiffusion kits, and fluoroscein conjugated immunoglobulin fractions for manufacturers, universities & laboratories. We also produce peroxidase conjugated antibodies and antisera to human proteins, immunoglobulins and fractions, complement and apolipoproteins. Our products are used by researchers and clinical laboratories. We produce antiserum in goats, rabbits, sheep and burros using antigens purified from normal serum. It is solid phase adsorbed by affinity chromatography so that the final product has no soluble antigens, which can sometimes interfere with sensitive testing procedures. Each antiserum is tested for specificity and titer by immunoelectrophoresis, reverse radial immunodiffusion and ochterlony.

The company was founded in 1974, has revenues of < USD 1 Million, has ~10 employees.

FDA Registration Number: 3019906

42 Products/Services (Click for related suppliers)

• Albumin Radial Immunodiffusion Test (FDA Code: CJQ / 862.1035)

An albumin test system is a device intended to measure the albumin concentration in serum and plasma. Albumin measurements are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.

• Albumin, FITC Conjugate (FDA Code: DDZ / 866.5040)

An albumin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the albumin (a plasma protein) in serum and other body fluids. Measurement of albumin aids in the diagnosis of kidney and intestinal diseases.

• Alpha-1-Acid-Glycoprotein Antigen (FDA Code: LKL / 866.5420)

Analpha- 1-glycoproteins immunological test system is a device that consists of the reagents used to measure by immunochemical techniquesalpha- 1-glycoproteins (a group of plasma proteins found in thealpha- 1 group when subjected to electrophoresis) in serum and other body fluids. Measurement of specificalpha- 1-glycoproteins may aid in the diagnosis of collagen (connective tissue) disorders, tuberculosis, infections, extensive malignancy, and diabetes.

• Alpha-1-Antitrypsin (FDA Code: DEM / 866.5130)

Analpha -1-antitrypsin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques thealpha -1-antitrypsin (a plasma protein) in serum, other body fluids, and tissues. The measurements aid in the diagnosis of several conditions including juvenile and adult cirrhosis of the liver. In addition,alpha -1-antitrypsin deficiency has been associated with pulmonary emphysema.

• Anti-kappa Antiserum (FDA Code: DFH / 866.5550)

An immunoglobulin (light chain specific) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques both kappa and lambda types of light chain portions of immunoglobulin molecules in serum, other body fluids, and tissues. In some disease states, an excess of light chains are produced by the antibody-forming cells. These free light chains, unassociated with gamma globulin molecules, can be found in a patient's body fluids and tissues. Measurement of the various amounts of the different types of light chains aids in the diagnosis of multiple myeloma (cancer of antibody-forming cells), lymphocytic neoplasms (cancer of lymphoid tissue), Waldenstrom's macroglobulinemia (increased production of large immunoglobulins), and connective tissue diseases such as rheumatoid arthritis or systemic lupus erythematosus.

• Antithrombin III Control (FDA Code: DDQ / 864.7060)

An antithrombin III assay is a device that is used to determine the plasma level of antithrombin III (a substance which acts with the anticoagulant heparin to prevent coagulation). This determination is used to monitor the administration of heparin in the treatment of thrombosis. The determination may also be used in the diagnosis of thrombophilia (a congenital deficiency of antithrombin III).

• Bence-Jones Protein (FDA Code: CZQ / 866.5150)

A Bence-Jones proteins immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the Bence-Jones proteins in urine and plasma. Immunoglobulin molecules normally consist of pairs of polypeptide chains (subunits) of unequal size (light chains and heavy chains) bound together by several disulfide bridges. In some cancerous conditions, there is a proliferation of one plasma cell (antibody-producing cell) with excess production of light chains of one specific kind (monoclonal light chains). These free homogeneous light chains not associated with an immunoglobulin molecule can be found in urine and plasma, and have been called Bence-Jones proteins. Measurement of Bence-Jones proteins and determination that they are monoclonal aid in the diagnosis of multiple myeloma (malignant proliferation of plasma cells), Waldenstrom's macroglobulinemia (increased production of large immunoglobulins by spleen and bone marrow cells), leukemia (cancer of the blood-forming organs), and lymphoma (cancer of the lymphoid tissue).

• C-Reactive Protein Test System (FDA Code: DCN / 866.5270)

A C-reactive protein immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the C-reactive protein in serum and other body fluids. Measurement of C-reactive protein aids in evaluation of the amount of injury to body tissues.

• Complement C1q (FDA Code: DAK / 866.5240)

A complement components immunological test system is a device that consists of the reagents used to measure by immunochemical techniques complement components C1q, C1r, C1s, C2, C3, C4, C5, C6, C7, C8, and C9, in serum, other body fluids, and tissues. Complement is a group of serum proteins which destroy infectious agents. Measurements of these proteins aids in the diagnosis of immunologic disorders, especially those associated with deficiencies of complement components.

• Complement C1s (FDA Code: DBA / 866.5250)

A complement C1inhibitor (inactivator) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the complement C1inhibitor (a plasma protein) in serum. Complement C1inhibitor occurs normally in plasma and blocks the action of the C1component of complement (a group of serum proteins which destroy infectious agents). Measurement of complement C1inhibitor aids in the diagnosis of hereditary angioneurotic edema (increased blood vessel permeability causing swelling of tissues) and a rare form of angioedema associated with lymphoma (lymph node cancer).

• Complement C3 (FDA Code: CZW / 866.5240)

• Complement C3 Activator (FDA Code: DAC / 866.5260)

A complement C3binactivator immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the complement C3binactivator (a plasma protein) in serum. Complement is a group of serum proteins that destroy infectious agents. Measurement of complement C3binactivator aids in the diagnosis of inherited antibody dysfunction.

• Complement C4 (FDA Code: DBI / 866.5240)

• Complement C5 (FDA Code: DAY / 866.5240)

• Complement Protein (FDA Code: DHL / 866.4100)

A complement reagent is a device that consists of complement, a naturally occurring serum protein from any warm-blooded animal such as guinea pigs, that may be included as a component part of serological test kits used in the diagnosis of disease.

• Control Antiserum Antigen FC Test (FDA Code: DBN / 866.5530)

An immunoglobulin G (Fc fragment specific) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the Fc (carbohydrate containing) fragment of immunoglobulin G (resulting from breakdown of immunoglobulin G antibodies) in urine, serum, and other body fluids. Measurement of immunoglobulin G Fc fragments aids in the diagnosis of plasma cell antibody-forming abnormalities, e.g., gamma heavy chain disease.

• Control Antiserum Antigen Ferritin IGA (FDA Code: CZM / 866.5510)

An immunoglobulins A, G, M, D, and E immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the immunoglobulins A, G, M, D, an E (serum antibodies) in serum. Measurement of these immunoglobulins aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents.

• Control Antiserum Antigen Ferritin IGE (FDA Code: DFM / 866.5510)

• Control Antiserum Antigen Ferritin IGG (FDA Code: DGD / 866.5510)

• Control Antiserum Antigen Ferritin IGM (FDA Code: DFL / 866.5550)

• Control Antiserum/Antigen

• FAB Fragment Specific Control (FDA Code: DFK / 866.5520)

An immunoglobulin G (Fab fragment specific) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the Fab antigen-binding fragment resulting from breakdown of immunoglobulin G antibodies in urine, serum, and other body fluids. Measurement of Fab fragments of immunoglobulin G aids in the diagnosis of lymphoproliferative disorders, such as multiple myeloma (tumor of bone marrow cells), Waldenstrom's macroglobulinemia (increased immunoglobulin production by the spleen and bone marrow cells), and lymphoma (tumor of the lymphoid tissues).

• Factor B Antiserum (FDA Code: JZH / 866.5320)

A properdin factor B immunological test system is a device that consists of the reagents used to measure by immunochemical techniques properdin factor B in serum and other body fluids. The deposition of properdin factor B in body tissues or a corresponding depression in the amount of properdin factor B in serum and other body fluids is evidence of the involvement of the alternative to the classical pathway of activation of complement (a group of plasma proteins which cause the destruction of cells which are foreign to the body). Measurement of properdin factor B aids in the diagnosis of several kidney diseases, e.g., chronic glomerulonephritis (inflammation of the glomeruli of the kidney), lupus nephritis (kidney disease associated with a multisystem autoimmune disease, systemic lupus erythematosus), as well as several skin diseases, e.g., dermititis herpetiformis (presence of vesicles on the skin that burn and itch), and pemphigus vulgaris (large vesicles on the skin). Other diseases in which the alternate pathway of complement activation has been implicated include rheumatoid arthritis, sickle cell anemia, and gram-negative bacteremia.

• Ferritin (FDA Code: DBF / 866.5340)

A ferritin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the ferritin (an iron-storing protein) in serum and other body fluids. Measurements of ferritin aid in the diagnosis of diseases affecting iron metabolism, such as hemochromatosis (iron overload) and iron deficiency amemia.

• Fibrinogen Test (FDA Code: GIS / 864.7340)

A fibrinogen determination system is a device that consists of the instruments, reagents, standards, and controls used to determine the fibrinogen levels in disseminated intravascular coagulation (nonlocalized clotting within the blood vessels) and primary fibrinolysis (the dissolution of fibrin in a blood clot).

• FITC FAB Control (FDA Code: DCB / 866.5520)

• Haptoglobin (FDA Code: DAD / 866.5460)

A haptoglobin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the haptoglobin (a protein that binds hemoglobin, the oxygen-carrying pigment in red blood cells) in serum. Measurement of haptoglobin may aid in the diagnosis of hemolytic diseases (diseases in which the red blood cells rupture and release hemoglobin) related to the formation of hemoglobin-haptoglobin complexes and certain kidney diseases.

• Hemopexin (FDA Code: CZX / 866.5490)

• IGA Control (FDA Code: CZP / 866.5510)

• IgD Antisera (FDA Code: CZJ / 866.5510)

• IgE Control (FDA Code: DGC / 866.5510)

• IgG Control (FDA Code: DEW / 866.5510)

• Immunoglobulin G FC Fragment Specific Antisera (FDA Code: DAS / 866.5530)

• Immunoglobulin M (IgM) (FDA Code: DFT / 866.5550)

• Lambda Antiserum (FDA Code: DEH / 866.5550)

• Lipoproteins Radial Immunodiffusion Test (FDA Code: JHP / 862.1475)

A lipoprotein test system is a device intended to measure lipoprotein in serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.

• Prealbumin Antiserum (FDA Code: JZJ / 866.5060)

A prealbumin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the prealbumin (a plasma protein) in serum and other body fluids. Measurement of prealbumin levels in serum may aid in the assessment of the patient's nutritional status.

• Protein Fractionation Immunodiffusion Test (FDA Code: JQK / 862.1630)

A protein (fractionation) test system is a device intended to measure protein fractions in blood, urine, cerebrospinal fluid, and other body fluids. Protein fractionations are used as an aid in recognizing abnormal proteins in body fluids and genetic variants of proteins produced in diseases with tissue destruction.

• Radial Immunodiffusion Plates and Equipment (FDA Code: JZQ / 866.4800)

A radial immunodiffusion plate for clinical use is a device that consists of a plastic plate to which agar gel containing antiserum is added. In radial immunodiffusion, antigens migrate through gel which originally contains specific antibodies. As the reagents come in contact with each other, they combine to form a precipitate that is trapped in the gel matrix and immobilized.

• Rhodamine Conjugated FAB Fragment (FDA Code: DBY / 866.5520)

• Transferrin Antigen (FDA Code: DDG / 866.5880)

A transferrin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the transferrin (an iron-binding and transporting serum protein) in serum, plasma, and other body fluids. Measurement of transferrin levels aids in the diagnosis of malnutrition, acute inflammation, infection, and red blood cell disorders, such as iron deficiency anemia.

• Whole Human Serum (FDA Code: DGR / 866.5700)

A whole human plasma or serum immunological test system is a device that consists of reagents used to measure by immunochemical techniques the proteins in plasma or serum. Measurements of proteins in plasma or serum aid in the diagnosis of any disease concerned with abnormal levels of plasma or serum proteins, e.g., agammaglobulinemia, allergies, multiple myeloma, rheumatoid vasculitis, or hereditary angioneurotic edema.